{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:22:19Z","timestamp":1771564939383,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1245\/s10434-020-09099-w","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T20:02:50Z","timestamp":1600372970000},"page":"1642-1653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Extracapsular Spread in Melanoma Lymphadenopathy: Prognostic Implications, Classification, and Management"],"prefix":"10.1245","volume":"28","author":[{"given":"Michelle","family":"Lo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyss","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryckie","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Peach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Dewar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Moncrieff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"8","key":"9099_CR1","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","volume":"25","author":"JE Gershenwald","year":"2018","unstructured":"Gershenwald JE, Scolyer RA. Melanoma staging: American joint committee on cancer (AJCC) 8th edition and beyond. Ann Surg Oncol. 2018;25(8):2105\u201310.","journal-title":"Ann Surg Oncol"},{"key":"9099_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/978-3-642-23499-6_200162","volume-title":"Encyclopedia of Otolaryngology, Head and Neck Surgery","author":"JR Clark","year":"2013","unstructured":"Clark JR, Shaw D. Extracapsular spread. In: Kountakis SE (ed). Encyclopedia of otolaryngology, head and neck surgery. Berlin: Springer; 2013, pp. 851\u2013852. https:\/\/doi.org\/10.1007\/978-3-642-23499-6_200162."},{"issue":"9","key":"9099_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(15)00187-4","volume":"16","author":"MA Henderson","year":"2015","unstructured":"Henderson MA, Burmeister BH, Ainslie J, et al. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02\/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Lancet Oncol. 2015;16(9):1049\u201360.","journal-title":"Lancet Oncol."},{"issue":"24","key":"9099_CR4","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1002\/cncr.24627","volume":"115","author":"S Agrawal","year":"2009","unstructured":"Agrawal S, Kane JM 3rd, Guadagnolo BA, Kraybill WG, Ballo MT. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer. 2009;115(24):5836\u201344.","journal-title":"Cancer."},{"issue":"2","key":"9099_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0360-3016(99)00431-9","volume":"46","author":"RJ Lee","year":"2000","unstructured":"Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Jia C, Kraybill WG. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2000;46(2):467\u201374.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"16","key":"9099_CR6","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1200\/JCO.2004.12.177","volume":"22","author":"DJ Dewar","year":"2004","unstructured":"Dewar DJ, Newell B, Green MA, Topping AP, Powell BWEM, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol. 2004;22(16):3345\u20139.","journal-title":"J Clin Oncol."},{"issue":"11","key":"9099_CR7","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.0.CO;2-Q","volume":"91","author":"H Starz","year":"2001","unstructured":"Starz H, Balda BR, Kr\u00e4mer KU, B\u00fcchels H, Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91(11):2110\u201321.","journal-title":"Cancer."},{"issue":"10","key":"9099_CR8","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/annonc\/mdl176","volume":"17","author":"ACJ van Akkooi","year":"2006","unstructured":"van Akkooi ACJ, de Wilt JHW, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<\u20090.1\u00a0mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol. 2006;17(10):1578\u201385. https:\/\/doi.org\/10.1093\/annonc\/mdl176.","journal-title":"Ann Oncol."},{"issue":"23","key":"9099_CR9","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211\u201322.","journal-title":"N Engl J Med."},{"issue":"6","key":"9099_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757\u201367.","journal-title":"Lancet Oncol."},{"key":"9099_CR11","unstructured":"Melanoma: assessment and management. Guidance and guidelines. NICE. https:\/\/www.nice.org.uk\/guidance\/ng14. Accessed 22 Nov 2018."},{"issue":"4","key":"9099_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.6004\/jnccn.2019.0018","volume":"17","author":"DG Coit","year":"2019","unstructured":"Coit DG, Thompson JA, Albertini MR, et al. Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(4):367\u2013402.","journal-title":"J Natl Compr Canc Netw."},{"key":"9099_CR13","unstructured":"U.S. Department of Health and Human Services: Food and Drug Administration. Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics. FDA.gov. https:\/\/www.fda.gov\/media\/71195\/download. Published December 2108. Accessed 13 Jun 2020."},{"issue":"6","key":"9099_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472\u201392.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"9099_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2133.2007.07937.x","volume":"157","author":"S Debarbieux","year":"2007","unstructured":"Debarbieux S, Duru G, Dalle S, B\u00e9atrix O, Balme B, Thomas L. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol. 2007;157(1):58\u201367. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07937.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"9099_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jamcollsurg.2005.03.029","volume":"201","author":"MS Sabel","year":"2005","unstructured":"Sabel MS, Griffith K, Sondak VK, et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg. 2005;201(1):37\u201347.","journal-title":"J Am Coll Surg."},{"issue":"11","key":"9099_CR17","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1245\/s10434-008-0087-8","volume":"15","author":"MD Moncrieff","year":"2008","unstructured":"Moncrieff MD, Martin R, O\u2019Brien CJ, et al. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients? Ann Surg Oncol. 2008;15(11):3022\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"9099_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599\u2013609.","journal-title":"N Engl J Med."},{"issue":"8","key":"9099_CR19","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1200\/jco.2002.08.024","volume":"20","author":"UNM Rao","year":"2002","unstructured":"Rao UNM, Ibrahim J, Flaherty LE, Richards J, Kirkwood JM. Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of eastern cooperative oncology group trial E1690. J Clin Oncol. 2002;20(8):2053\u20137. https:\/\/doi.org\/10.1200\/jco.2002.08.024.","journal-title":"J Clin Oncol."},{"issue":"9","key":"9099_CR20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/archsurg.1989.01410090061014","volume":"124","author":"A Calabro","year":"1989","unstructured":"Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg. 1989;124(9):1051\u20135.","journal-title":"Arch Surg."},{"issue":"23","key":"9099_CR21","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1056\/NEJMe1704290","volume":"376","author":"D Coit","year":"2017","unstructured":"Coit D. The enigma of regional lymph nodes in melanoma. N Engl J Med. 2017;376(23):2280\u20131.","journal-title":"N Engl J Med."},{"issue":"16","key":"9099_CR22","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong S-J, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622\u201334.","journal-title":"J Clin Oncol."},{"issue":"4","key":"9099_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, et al. The immune landscape of cancer. Immunity. 2018;48(4):812\u201330.e14.","journal-title":"Immunity."},{"issue":"7637","key":"9099_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541(7637):321\u201330.","journal-title":"Nature."},{"issue":"11","key":"9099_CR25","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","volume":"75","author":"MWL Teng","year":"2015","unstructured":"Teng MWL, Ngiow SF, Ribas A, Smyth MJ. Classifying cancers based on T-cell infiltration and PD-L1. Cancer Res. 2015;75(11):2139\u201345.","journal-title":"Cancer Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09099-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T01:23:41Z","timestamp":1631841821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09099-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["9099"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09099-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"9 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}